Login / Signup

Molecular Complexity as a Driver for Chemical Process Innovation in the Pharmaceutical Industry.

Seb CailleSheng CuiMargaret M FaulSteven M MennenJason S TedrowShawn D Walker
Published in: The Journal of organic chemistry (2019)
A Perspective of our work in the development of innovative synthetic methods within the discipline of Process Research and Development is presented. Through an overview of some of the programs that we have worked on during the past decade, we have selected cases studies to illustrate the challenges faced in development of robust chemical processes for molecules on a multi-kilogram scale. The examples have been selected to demonstrate the innovative chemistry being developed within our laboratories with a focus on fragment design, asymmetric synthesis, new synthetic reagents, and the methods that have allowed us to deliver cost-effective syntheses under reduced timelines in an increasingly competitive environment. The technical challenges are presented in the context of molecule complexity that while increasing in the portfolio of small molecules being developed inspires us to deliver new solutions. Overall, our goal is to highlight the exciting work that can be done within our field to support the discovery and delivery of medicines to patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • public health
  • small molecule
  • peritoneal dialysis
  • prognostic factors
  • case control
  • single molecule